Session Datesort descending
“The Role of Innate Immunity in MDS Pathogenesis” 04/09/2018 - 12:00pm to 1:00pm
“Sickle Cell Disease Management in Adults – New Advances and Future Challenges” 04/16/2018 - 12:00pm to 1:00pm
“Missed Germline Pathogenic Mutations: Causes, Consequences & Corrective Actions" 04/23/2018 - 12:00pm to 1:00pm
"Too Fit to Quit: Treating Older Adults with AML" and “Checkpoint Inhibitors in Metastatic Gynecologic Malignancies” 04/30/2018 - 12:00pm to 1:00pm
“Drug De-Development: An Opportunity to Reduce Costs of Cancer Care” 05/07/2018 - 12:00pm to 1:00pm
“EGFR Mutation-Positive Lung Cancer in 2018” 05/14/2018 - 12:00pm to 1:00pm
“Phase II Trial of Pembrolizumab (Pembro) Plus 1 mg/kg Ipilimumab (ipi) Immediately Following Progression on Anti-PD-1-Ab in Melanoma (mel)” 05/21/2018 - 12:00pm to 1:00pm
Fellows QI/Safety Day 06/11/2018 - 12:00pm to 1:00pm
“Playing Mind Games: Therapeutic Approaches to Primary CNS Lymphoma” and “Beyond Transfusions – Novel Strategies for Treatment of Beta-Thalassemia” 06/18/2018 - 12:00pm to 1:00pm
“Evolving Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Myeloma” and “Defining Response: A Closer Look at Biomarkers to Predict Response to Checkpoint Blockade in Solid Tumors” 06/25/2018 - 12:00pm to 1:00pm

Pages